Rare Ovarian Cancer GOG 241

March 13, 2013

Location: The Hospital of Central Connecticut

A GCIG Intergroup Multigroup Multicenter Phase III Trialof Open Label Carboplatin and Paclitaxel +/- NCI Supplies Agents Bevacizumab Compared with Oxaliplatin and Capecitabine +/- Bevacizumab as First Line Chemotherapy in Patients with Mucinous Epithelial Ovarian or Fallopian Tube Cancer.